Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) Interest Expenses (2019 - 2024)

Historic Interest Expenses for AdaptHealth (AHCO) over the last 6 years, with Q3 2024 value amounting to $31.4 million.

  • AdaptHealth's Interest Expenses fell 271.47% to $31.4 million in Q3 2024 from the same period last year, while for Jun 2025 it was $31.4 million, marking a year-over-year decrease of 7606.36%. This contributed to the annual value of $130.3 million for FY2023, which is 1908.81% up from last year.
  • According to the latest figures from Q3 2024, AdaptHealth's Interest Expenses is $31.4 million, which was down 271.47% from $33.0 million recorded in Q2 2024.
  • In the past 5 years, AdaptHealth's Interest Expenses ranged from a high of $33.5 million in Q4 2023 and a low of $7.5 million during Q2 2020
  • Over the past 5 years, AdaptHealth's median Interest Expenses value was $25.6 million (recorded in 2021), while the average stood at $24.9 million.
  • Per our database at Business Quant, AdaptHealth's Interest Expenses plummeted by 4887.6% in 2020 and then surged by 20936.92% in 2021.
  • Quarter analysis of 5 years shows AdaptHealth's Interest Expenses stood at $13.6 million in 2020, then soared by 88.26% to $25.6 million in 2021, then increased by 19.12% to $30.5 million in 2022, then increased by 9.76% to $33.5 million in 2023, then decreased by 6.14% to $31.4 million in 2024.
  • Its last three reported values are $31.4 million in Q3 2024, $33.0 million for Q2 2024, and $32.5 million during Q1 2024.